Driving Attendance At Investigators' Meetings In Clinical Research

Attendance at investigators’ meetings is rarely a matter of interest; it is a calculated decision made by sites balancing clinic schedules, staffing gaps, and participant care. This article examines the critical factors—often decided months before an invitation is sent—that determine whether a site team can justify the "cost" of stepping away. Explore the impact of upstream planning, illustrating how choices in timing, location, and format create or remove friction long before a registration deadline.

By prioritizing predictability and role-relevant content over administrative fillers like routine GCP training, sponsors can ensure meetings feel workable and worth the effort. Ultimately, attendance is a signal of how well a study respects a site’s reality. Read the full article to discover how to design meetings that don’t just fill seats, but provide the clarity and direction necessary for trial success.